Eli Lilly
LLY
LLY
3,630 hedge funds and large institutions have $676B invested in Eli Lilly in 2024 Q3 according to their latest regulatory filings, with 245 funds opening new positions, 1,557 increasing their positions, 1,377 reducing their positions, and 114 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,630
Holders Change
+91
Holders Change %
+2.57%
% of All Funds
52.5%
Holding in Top 10
465
Holding in Top 10 Change
-82
Holding in Top 10 Change %
-14.99%
% of All Funds
6.73%
New
245
Increased
1,557
Reduced
1,377
Closed
114
Calls
$9.13B
Puts
$10.4B
Net Calls
-$1.24B
Net Calls Change
+$432M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$739M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$712M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$561M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$518M |
| 5 |
Amundi
Paris,
France
|
+$500M |
Top Sellers
| 1 |
Primecap Management
Pasadena,
California
|
-$1.71B |
| 2 |
BlackRock
New York
|
-$1.34B |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$1.29B |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$561M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$551M |
